the investigators conclude that the combined use of mabs directed against fixative-resistant epitopes of the cd30 , cd45ro , cd45ra , and l26 antigens and cytokeratins is essential for the correct diagnosis and treatment of these equivocal cases .
C0003316
epitopes
C0003320
antigens